Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...